FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans Hillege

Research Profile

Disorders

Concepts & Ideas

Physiology

Glomerular Filtration Rate

Geographic Areas

Netherlands

Chemicals & Drugs

Anatomy

Kidneys

Co-author Network

Publications

TOP 3
Peter van der Meer; John G Cleland; Gad Cotter; Beth A Davison; Michael M Givertz; Hans L Hillege; George A Mansoor; Barry M Massie; Marco Metra; Christopher M O'Connor; Piotr Ponikowski; Douwe Postmus; John R Teerlink; Adriaan A Voors
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.
Andrea R Beyer; Pieter A de Graeff; Barbara Fasolo; Lawrence D Phillips; Hans L Hillege
Risk perception of prescription drugs: results of a survey among experts in the European regulatory network.
Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Pim van der Harst; Dirk J van Veldhuisen; Adriaan A Voors; Stephan J Bakker; Wiek H van Gilst
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans Hillege (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Peter van der Meer; John G Cleland; Gad Cotter; Beth A Davison; Michael M Givertz; Hans L Hillege; George A Mansoor; Barry M Massie; Marco Metra; Christopher M O'Connor; Piotr Ponikowski; Douwe Postmus; John R Teerlink; Adriaan A Voors
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.
Journal of the American College of Cardiology 2013;61(19):1973-81.
2013: Andrea R Beyer; Pieter A de Graeff; Barbara Fasolo; Lawrence D Phillips; Hans L Hillege
Risk perception of prescription drugs: results of a survey among experts in the European regulatory network.
Medical decision making : an international journal of the Society for Medical Decision Making 2013;33(4):579-92.
2013: Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Pim van der Harst; Dirk J van Veldhuisen; Adriaan A Voors; Stephan J Bakker; Wiek H van Gilst
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
European heart journal 2013;34(19):1424-31.
2013: Mariusz K Szymanski; A H Jan Danser; Ingrid M Garrelds; Hans L Hillege; Regien G Schoemaker
Elevated sensitivity to cardiac ischemia in proteinuric rats is independent of adverse cardiac remodeling.
Journal of hypertension 2013;31(5):966-74.
2013: Dirk J van Veldhuisen; Adriaan A Voors; Arno W Hoes; Tiny Jaarsma; Gerard C M Linssen; Walter J Paulus; Jan G P Tijssen; Wiek H van Gilst; Hans L Hillege
B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
Journal of the American College of Cardiology 2013;61(14):1498-506.
2013: H F Groenveld; Hans L Hillege; J G P Tijssen; Y S Tuininga; Maarten P van den Berg; M Alings; H J G M Crijns; Dirk J van Veldhuisen; I C Van Gelder
Rate control in atrial fibrillation, insight into the RACE II study.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2013;21(4):199-204.
2013: Peter Johansson; Ivonne Lesman-Leegte; Johan Lundgren; Robbert Sanderman; Dirk J van Veldhuisen; Hans L Hillege; Arno Hoes; Tiny Jaarsma
Time-course of depressive symptoms in patients with heart failure.
Journal of psychosomatic research 2013;74(3):238-43.
2013: Niek Verweij; Hongjuan Yu; Wiek H van Gilst; Dirk J van Veldhuisen; Folkert W Asselbergs; Stephan J L Bakker; Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Hasan Mahmud; Irene Mateo Leach; Patricia B Munroe; Herman H W Silljé; Joachim Struck; Pim van der Harst
Genome-wide association study on plasma levels of midregional-proadrenomedullin and C-terminal-pro-endothelin-1.
Hypertension 2013;61(3):602-8.
2013: Hessel F Groenveld; Hans L Hillege; Jan G P Tijssen; Maarten P van den Berg; Isabelle C Van Gelder; Dirk J van Veldhuisen; Marco Alings; Harry J G M Crijns
Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).
Journal of the American College of Cardiology 2013;61(7):741-8.
2013: Arjen E de Vries; Hans L Hillege; Tiny Jaarsma; Maurice Mw Nieuwenhuis; Martje H L van der Wal; Rene B van Dijk; Richard M de Jong; Rene J Jorna
Perceived barriers of heart failure nurses and cardiologists in using clinical decision support systems in the treatment of heart failure patients.
BMC medical informatics and decision making 2013;13():54.
2013: Arjen E de Vries; Richard M de Jong; Tiny Jaarsma; Maurice M W Nieuwenhuis; Martje H L van der Wal; Rene B van Dijk; Hans L Hillege
Health professionals' expectations versus experiences of internet-based telemonitoring: survey among heart failure clinics.
Journal of medical Internet research 2013;15(1):e4.
2013: Tialda Hoekstra; Tiny Jaarsma; Robbert Sanderman; Dirk J van Veldhuisen; Hans L Hillege; Ivonne Lesman-Leegte
Quality of life and survival in patients with heart failure.
European journal of heart failure 2013;15(1):94-102.
2012: Frank P Brouwers; Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen
Comparing new onset heart failure with reduced ejection fraction and new onset heart failure with preserved ejection fraction: an epidemiologic perspective.
Current heart failure reports 2012;9(4):363-8.
2012: Paul J W H Kappelle; André P van Beek; Robin P F Dullaart; Hans L Hillege; Bruce H R Wolffenbuttel
The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study.
European journal of internal medicine 2012;23(8):755-9.
2012: Arjen E de Vries; Hans L Hillege; Wendy Bedijn; Richard M de Jong; Martje H L van der Wal; Rene B van Dijk; Tiny Jaarsma
Follow-up and treatment of an instable patient with heart failure using telemonitoring and a computerised disease management system: a case report.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2012;11(4):432-8.
2012: Suzan Willemsen; Jasper W L Hartog; Hans L Hillege; Tiny Jaarsma; Joline F Roze; Casper Schalkwijk; Iwan C C van der Horst; Peter van der Meer; Dirk J van Veldhuisen; Adriaan A Voors
The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.
American heart journal 2012;164(5):742-749.e3.
2012: Paul A Smink; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort; Hans L Hillege; Hiddo J Lambers Heerspink; Dick De Zeeuw
Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;60(5):804-11.
2012: Douwe Postmus; Ewout W Steyerberg; Gimon de Graaf; Hans L Hillege; Erik Buskens
A method for the early health technology assessment of novel biomarker measurement in primary prevention programs.
Statistics in medicine 2012;31(23):2733-44.
2012: Ali Abbasi; Joline W J Beulens; Eva Corpeleijn; Paul E de Jong; Rijk O B Gans; Ron T Gansevoort; Hans L Hillege; gerjan navis; Linda M Peelen; Douwe Postmus; Janin Schulte; Ronald P Stolk; Joachim Struck; Pim van der Harst; Stephan J L Bakker
Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality.
Journal of the American Heart Association 2012;1(5):e002956.
2012: H G Freling; Hans L Hillege; M R M Jongbloed; B J M Mulder; P G Pieper; M C Post; Gertjan Tj Sieswerda; Arie P J van Dijk; Joost P van Melle; Y J van Slooten; T P Willems
Prosthetic valves in adult patients with congenital heart disease: Rationale and design of the Dutch PROSTAVA study.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2012;20(10):419-24.
2012: Frank P Brouwers; Rudolf A de Boer; Paul E de Jong; Dick de Zeeuw; Rijk O Gans; Ron T Gansevoort; Hans L Hillege; Joachim Struck; Pim van der Harst; Wiek H van Gilst; Stephan J Bakker
Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population.
Heart (British Cardiac Society) 2012;98(18):1348-53.
2012: Rudolf A de Boer; Ron T Gansevoort; Stephan J L Bakker; Hasan Mahmud; Nicolas F Schroten; Mariusz K Szymanski; Pim van der Harst; Wiek H van Gilst; Dirk J van Veldhuisen; Hans L Hillege
Plasma renin and outcome in the community: data from PREVEND.
European heart journal 2012;33(18):2351-9.
2012: Lieneke Scheven; L Joost van Pelt; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort; Hans L Hillege; Jenny E Kootstra; Hiddo J Lambers Heerspink
High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
European heart journal 2012;33(18):2272-81.
2012: Marcelle D Smit; Peter P van Geel; Dirk J van Veldhuisen; Ismaël D Achekar; Hans L Hillege; Alexander H Maass; Marjolein L Moes; Isabelle C Van Gelder
The importance of whether atrial fibrillation or heart failure develops first.
European journal of heart failure 2012;14(9):1030-40.
2012: Lennaert Kleijn; Wiek H van Gilst; Adriaan A Voors; Dirk J van Veldhuisen; Anne M S Belonje; Rudolf A de Boer; Sudip Ghosh; Hans L Hillege; Tiny Jaarsma; Joseph Kim; Peter van der Meer
Inflammation and anaemia in a broad spectrum of patients with heart failure.
Heart (British Cardiac Society) 2012;98(16):1237-41.
2012: Marie Louise Luttik; M Berger; M Brons; R de Jong; Hans L Hillege; A Hoes; Tiny Jaarsma; G Linssen; D J Lok; Dirk J van Veldhuisen
Design and methodology of the COACH-2 (Comparative study on guideline adherence and patient compliance in heart failure patients) study: HF clinics versus primary care in stable patients on optimal therapy.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2012;20(7-8):307-12.
2012: Mattia A E Valente; Kevin Damman; Peter H J M Dunselman; Hans L Hillege; Adriaan A Voors
Urinary proteins in heart failure.
Progress in cardiovascular diseases 2012;55(1):44-55.
2012: A Abbasi; Eva Corpeleijn; R O B Gans; Ron T Gansevoort; Hans L Hillege; E Meijer; gerjan navis; D Postmus; R P Stolk; Joachim Struck; S J L Bakker
Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
Diabetologia 2012;55(7):1963-70.
2012: Mariusz K Szymanski; René A Tio; Antoon T M Willemsen; Lars Stegger; Rudi A Dierckx; Hans L Hillege; Silvana Kruizinga; Michael A Schäfers; Riemer H J A Slart
Use of gated 13N-NH3 micro-PET to examine left ventricular function in rats.
Nuclear medicine and biology 2012;39(5):724-9.
2012: Mariusz K Szymanski; Wiek H van Gilst; Rudolf A de Boer; Gerjan J Navis; Hans L Hillege
Animal models of cardiorenal syndrome: a review.
Heart failure reviews 2012;17(3):411-20.
2012: Marjan Alssema; Stephan J L Bakker; Ron T Gansevoort; Martijn W Heymans; Hans L Hillege; Albert Hofman; Rachel S Newson; Giel Nijpels; Coen D A Stehouwer; Jacqueline C M Witteman; Jacqueline M Dekker
One risk assessment tool for cardiovascular disease, type 2 diabetes, and chronic kidney disease.
Diabetes care 2012;35(4):741-8.
2012: Gert van Valkenhoef; Jing Zhao; Bert de Brock; Hans L Hillege; Tommi Tervonen; Douwe Postmus
Multicriteria benefit-risk assessment using network meta-analysis.
Journal of clinical epidemiology 2012;65(4):394-403.
2012: Nicolas F Schroten; Mariusz K Szymanski; Dirk J van Veldhuisen; Carlo A J M Gaillard; Hans L Hillege; Rudolf A de Boer
New roles for renin and prorenin in heart failure and cardiorenal crosstalk.
Heart failure reviews 2012;17(2):191-201.
2012: Kevin Damman; gerjan navis; Dirk J van Veldhuisen; Adriaan A Voors; Hans L Hillege
Current and novel renal biomarkers in heart failure.
Heart failure reviews 2012;17(2):241-50.
2012: Douwe Postmus; Dirk J van Veldhuisen; Erik Buskens; Veli-Pekka Harjola; Tiny Jaarsma; Johan Lassus; James Lewsey; Marie Louise Luttik; Alexandre Mebazaa; Markku S Nieminen; Hans L Hillege
The COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failure.
European journal of heart failure 2012;14(2):168-75.
2012: Kevin Damman; gerjan navis; Tom D J Smilde; Pim van der Harst; Dirk J van Veldhuisen; Adriaan Voors; Hans L Hillege
Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure.
Heart (British Cardiac Society) 2012;98(4):319-24.
2012: Mireille E Emans; Yves G C J America; Branko Braam; Maarten J Cramer; Jan J J de Vries; Pieter A F M Doevendans; Hans L Hillege; Louis Meiss; Karien van der Putten; Birgitta K Velthuis; Carlo A J M Gaillard
Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging.
BMC cardiovascular disorders 2012;12():76.
2012: Ali Abbasi; Joline W J Beulens; Eva Corpeleijn; Paul E de Jong; Rijk O B Gans; Ron T Gansevoort; Hans L Hillege; Bernd Kowall; Christine Meisinger; gerjan navis; Linda M Peelen; Wolfgang Rathmann; Ronald P Stolk; Stephan J L Bakker
External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND study.
European journal of epidemiology 2012;27(1):47-52.
2011: Karim D Mahmoud; Ad F M van den Heuvel; Pieter J Vlaar; Felix Zijlstra; Hans L Hillege; Bart J G L de Smet
Usefulness of thrombus aspiration for the treatment of coronary stent thrombosis.
The American journal of cardiology 2011;108(12):1721-7.
2011: Douwe Postmus; Dirk J van Veldhuisen; Anees A Abdul Pari; Hans L Hillege; Tiny Jaarsma; Marie Louise Luttik; Erik Buskens
A trial-based economic evaluation of 2 nurse-led disease management programs in heart failure.
American heart journal 2011;162(6):1096-104.
2011: Youlan L Gu; Hans L Hillege; Serge Masson; Joachim Struck; Tarcisio Vago; Ad F M van den Heuvel; Dirk J van Veldhuisen; Adriaan A Voors; Felix Zijlstra; Stefan D Anker; Bart J G L de Smet
Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction.
Clinical research in cardiology : official journal of the German Cardiac Society 2011;100(12):1069-76.
2011: Kevin Damman; Hans L Hillege; Franco Cosmi; Aldo P Maggioni; Serge Masson; Laura Montagna; Cristina Opasich; Luigi Tavazzi; Gianni Tognoni; Dirk J van Veldhuisen; Adriaan Voors; Roberto Latini
Clinical outcome of renal tubular damage in chronic heart failure.
European heart journal 2011;32(21):2705-12.
2011: Hessel F Groenveld; Hans L Hillege; Adelita Ranchor; Jan G P Tijssen; Ype S Tuininga; Maarten P van den Berg; Isabelle C Van Gelder; Eric van Sonderen; Dirk J van Veldhuisen; A Marco Alings; Harry J G M Crijns
The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study.
Journal of the American College of Cardiology 2011;58(17):1795-803.
2011: Rosa Laura E van Loon; Magdalena van Osch-Gevers; Sally-Ann B Clur; Tammo Delhaas; Hans L Hillege; Livia Kapusta; Barbara J M Mulder; Lukas Rammeloo; Marcus T R Roofthooft; Jan L M Strengers; Arend D J ten Harkel; Rolf M F Berger
Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.
Circulation 2011;124(16):1755-64.
2011: Gerard C M Linssen; Michiel Rienstra; Isabelle C Van Gelder; Hans L Hillege; Tiny Jaarsma; Adriaan A Voors; Dirk J van Veldhuisen
Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
European journal of heart failure 2011;13(10):1111-20.
2011: Mariusz K Szymanski; Wiek H van Gilst; Dirk J van Veldhuisen; Kevin Damman; Hans L Hillege; Rudolf A de Boer
Prognostic value of renin and prorenin in heart failure patients with decreased kidney function.
American heart journal 2011;162(3):487-93.
2011: Kevin Damman; gerjan navis; Dirk J van Veldhuisen; Adriaan A Voors; Hans L Hillege
The cardiorenal syndrome in heart failure.
Progress in cardiovascular diseases 2011;54(2):144-53.
2011: Ali Abbasi; Eva Corpeleijn; P E de Jong; R O B Gans; Ron T Gansevoort; Hans L Hillege; gerjan navis; D Postmus; R P Stolk; Joachim Struck; S J L Bakker
Plasma procalcitonin and risk of type 2 diabetes in the general population.
Diabetologia 2011;54(9):2463-5.
2011: Marcelle D Smit; Jan G P Tijssen; Ype S Tuininga; Maarten P van den Berg; Isabelle C Van Gelder; Dirk J van Veldhuisen; Marco Alings; Harry J G M Crijns; Hessel F Groenveld; Hans L Hillege
Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study.
Journal of the American College of Cardiology 2011;58(9):942-9.
2011: Pieter J Vlaar; Felix Zijlstra; Hans L Hillege; David R Holmes; Karim D Mahmoud; Iwan C C van der Horst; Gert van Valkenhoef; Bart J G L de Smet
Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis.
Journal of the American College of Cardiology 2011;58(7):692-703.
2011: Jasper W L Hartog; Hans L Hillege; Yoran M Hummel; Jan L Posma; Dirk J van Veldhuisen; LM van Wijk; Adriaan Voors; Suzan Willemsen
Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure.
European journal of heart failure 2011;13(8):899-908.
2011: Paul J W H Kappelle; Frank Perton; Geesje M Dallinga-Thie; Hans L Hillege; Robin P F Dullaart
High plasma cholesteryl ester transfer but not CETP mass predicts incident cardiovascular disease: a nested case-control study.
Atherosclerosis 2011;217(1):249-52.
2011: Frank P Brouwers; Folkert Asselbergs; Hans L Hillege; Rudolf A de Boer; Ron T Gansevoort; Dirk J van Veldhuisen; Wiek H van Gilst
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT).
American heart journal 2011;161(6):1171-8.
2011: Riemer H J A Slart; Clark J Zeebregts; Hans L Hillege; Johan de Sutter; Rudi A J O Dierckx; Dirk J van Veldhuisen; Felix Zijlstra; René A Tio
Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(6):873-9.
2011: Ijsbrand T Klip; Iain Squire; Joachim Struck; Dirk J van Veldhuisen; Adriaan Voors; Stefan D Anker; Kenneth Dickstein; Hans L Hillege
Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction.
Heart (British Cardiac Society) 2011;97(11):892-8.
2011: Kevin Damman; Marie J Ng Kam Chuen; Robert J MacFadyen; Gregory Y H Lip; David Gaze; Paul O Collinson; Hans L Hillege; Wim van Oeveren; Adriaan Voors; Dirk J van Veldhuisen
Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.
Journal of the American College of Cardiology 2011;57(22):2233-41.
2011: Tommi Tervonen; Gert van Valkenhoef; Erik Buskens; Hans L Hillege; Douwe Postmus
A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysis.
Statistics in medicine 2011;30(12):1419-28.
2011: Nic J G M Veeger; Margriet Piersma-Wichers; Karina Meijer; Hans L Hillege
Minor bleeds alert for subsequent major bleeding in patients using vitamin K antagonists.
British journal of haematology 2011;153(4):508-14.
2011: Marcelle D Smit; Alexander H Maass; Hans L Hillege; Ans C P Wiesfeld; Dirk J van Veldhuisen; Isabelle C Van Gelder
Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy.
European journal of heart failure 2011;13(5):543-50.
2011: Ali Balci; Krystyna M Sollie; Barbara J M Mulder; Monique W M de Laat; Jolien Roos-Hesselink; Arie P J van Dijk; Elly M C J Wajon; Hubert W Vliegen; Willem Drenthen; Hans L Hillege; Jan G Aarnoudse; Dirk J van Veldhuisen; Petronella G Pieper
Associations between cardiovascular parameters and uteroplacental Doppler (blood) flow patterns during pregnancy in women with congenital heart disease: Rationale and design of the Zwangerschap bij Aangeboren Hartafwijking (ZAHARA) II study.
American heart journal 2011;161(2):269-275.e1.
2011: Rudolf A de Boer; Dirk J A Lok; Tiny Jaarsma; Peter van der Meer; Adriaan A Voors; Hans L Hillege; Dirk J van Veldhuisen
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction.
Annals of medicine 2011;43(1):60-8.
2011: Christopher S Coffey; Folkert W Asselbergs; Patricia R Hebert; Hans L Hillege; Qing Li; Jason H Moore; Wiek H van Gilst
The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels.
Cardiology research and practice 2011;2011():541467.
2011: Pieter J Vlaar; Bart J de Smet; Ad F van den Heuvel; Rutger L Anthonio; Gillian A Jessurun; Eng-Shiong Tan; Hans L Hillege; Felix Zijlstra
Operator dependence of outcome after primary percutaneous coronary intervention.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2011;6(6):760-7.
2011: Alan S Maisel; Nevin Katz; Hans L Hillege; Andrew Shaw; Pierluigi Zanco; Rinaldo Bellomo; Inder Anand; Stefan D Anker; Nadia Aspromonte; Sean M Bagshaw; Tomas Berl; Ilona Bobek; Dinna Cruz; Luciano Daliento; Andrew Davenport; Mikko Haapio; Andrew A House; Sunil Mankad; Peter McCullough; Alexandre Mebazaa; Alberto Palazzuoli; Piotr Ponikowski; Federico Ronco; Geoffrey R Sheinfeld; Sachin Soni; Giorgio Vescovo; Nereo Zamperetti; Claudio Ronco
Biomarkers in kidney and heart disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2011;26(1):62-74.
2010: Youlan L Gu; Marthe A Kampinga; Wouter G Wieringa; Marieke L Fokkema; Maarten W Nijsten; Hans L Hillege; Ad F M van den Heuvel; Eng S Tan; Gabija Pundziute; Rik van der Werf; Siyrous Hoseyni Guyomi; Iwan C C van der Horst; Felix Zijlstra; Bart J G L de Smet
Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
Circulation 2010;122(25):2709-17.
2010: Nic J G M Veeger; Felix Zijlstra; Hans L Hillege; Jan van der Meer
Fourteen-year follow-up from CABADAS: vitamin K antagonists or dipyridamole not superior to aspirin.
The Annals of thoracic surgery 2010;90(5):1515-21.
2010: Adriaan A Voors; Anne M S Belonje; Felix Zijlstra; Hans L Hillege; Stefan D Anker; Riemer H J A Slart; René A Tio; Arnoud W J van 't Hof; J Wouter Jukema; Hans Otto J Peels; José P S Henriques; Jurriën M ten Berg; Jeroen Vos; Wiek H van Gilst; Dirk J van Veldhuisen
A single dose of erythropoietin in ST-elevation myocardial infarction.
European heart journal 2010;31(21):2593-600.
2010: Reza Golestani; René Tio; Clark J Zeebregts; Aafke Zeilstra; Rudi A Dierckx; Hendrikus H Boersma; Hans L Hillege; Riemer H J A Slart
Abdominal aortic calcification detected by dual X-ray absorptiometry: A strong predictor for cardiovascular events.
Annals of medicine 2010;42(7):539-45.
2010: Kevin Damman; Adriaan Voors; Hans L Hillege; gerjan navis; Philippe Lechat; Dirk J van Veldhuisen; Henry J Dargie
Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality.
European journal of heart failure 2010;12(9):974-82.
2010: Ali Abbasi; Eva Corpeleijn; Douwe Postmus; Ron T Gansevoort; Paul E de Jong; Rijk O B Gans; Joachim Struck; Hans L Hillege; Ronald P Stolk; gerjan navis; Stephan J L Bakker
Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome.
The Journal of clinical endocrinology and metabolism 2010;95(9):E26-31.
2010: Kevin Damman; Dirk J van Veldhuisen; gerjan navis; Vishal S Vaidya; Tom D J Smilde; B Daan Westenbrink; Joseph V Bonventre; Adriaan Voors; Hans L Hillege
Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.
Heart (British Cardiac Society) 2010;96(16):1297-302.
2010: Rosa Laura E van Loon; Marcus T R Roofthooft; Tammo Delhaas; Magdalena van Osch-Gevers; Arend D J ten Harkel; Jan L M Strengers; Ad Backx; Hans L Hillege; Rolf M F Berger
Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies.
The American journal of cardiology 2010;106(1):117-24.
2010: Isabelle C Van Gelder; Hessel F Groenveld; Harry J G M Crijns; Ype S Tuininga; Jan G P Tijssen; A Marco Alings; Hans L Hillege; Johanna A Bergsma-Kadijk; Jan H Cornel; Otto Kamp; Raymond Tukkie; Hans A Bosker; Dirk J van Veldhuisen; Maarten P van den Berg
Lenient versus strict rate control in patients with atrial fibrillation.
The New England journal of medicine 2010;362(15):1363-73.
2010: Iwan C C van der Horst; Rudolf A de Boer; Hans L Hillege; Frans Boomsma; Adriaan Voors; Dirk J van Veldhuisen
Neurohormonal profile of patients with heart failure and diabetes.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2010;18(4):190-6.
2010: R P F Dullaart; Frank Perton; Melanie M van der Klauw; Hans L Hillege; Wim J Sluiter
High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol.
Atherosclerosis 2010;208(2):537-42.
2010: John P Bentley; Folkert W Asselbergs; Christopher S Coffey; Patricia R Hebert; Jason H Moore; Hans L Hillege; Wiek H van Gilst
Cardiovascular risk associated with interactions among polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems.
PloS one 2010;5(9):e12757.
2010: V M van Deursen; Kevin Damman; Hans L Hillege; A P van Beek; Dirk J van Veldhuisen; Adriaan A Voors
Abnormal liver function in relation to hemodynamic profile in heart failure patients.
Journal of cardiac failure 2010;16(1):84-90.
2010: Pim van der Harst; Rudolf A de Boer; Nilesh J Samani; Liza S M Wong; Jardi Huzen; Veryan Codd; Hans L Hillege; Adriaan A Voors; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen
Telomere length and outcome in heart failure.
Annals of medicine 2010;42(1):36-44.
2010: Gerard C M Linssen; Stephan J L Bakker; Adriaan Voors; Ron T Gansevoort; Hans L Hillege; Paul E de Jong; Dirk J van Veldhuisen; Rijk O B Gans; Dick De Zeeuw
N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population.
European heart journal 2010;31(1):120-7.
2009: Ivonne Lesman-Leegte; Dirk J van Veldhuisen; Hans L Hillege; Debra Moser; Robbert Sanderman; Tiny Jaarsma
Depressive symptoms and outcomes in patients with heart failure: data from the COACH study.
European journal of heart failure 2009;11(12):1202-7.
2009: Liza S M Wong; Pim van der Harst; Rudolf A de Boer; Veryan Codd; Jardi Huzen; Nilesh J Samani; Hans L Hillege; Adriaan A Voors; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen
Renal dysfunction is associated with shorter telomere length in heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2009;98(10):629-34.
2009: Kevin Damman; Tiny Jaarsma; Adriaan A Voors; gerjan navis; Hans L Hillege; Dirk J van Veldhuisen
Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH).
European journal of heart failure 2009;11(9):847-54.
2009: Kevin Damman; Hans L Hillege; Dirk J van Veldhuisen
Albuminuria in heart failure: a CHARMing new risk factor?
Lancet 2009;374(9689):506-8.
2009: Gerard C M Linssen; Kevin Damman; Hans L Hillege; gerjan navis; Dirk J van Veldhuisen; Adriaan A Voors
Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure.
Circulation 2009;120(1):35-41.
2009: Bakhtawar K Mahmoodi; Ron T Gansevoort; Nic J G M Veeger; Abigail G Matthews; gerjan navis; Hans L Hillege; Jan van der Meer
Microalbuminuria and risk of venous thromboembolism.
JAMA : the journal of the American Medical Association 2009;301(17):1790-7.
2009: Adriaan A Voors; Stephan von Haehling; Stefan D Anker; Hans L Hillege; Joachim Struck; Oliver Hartmann; Andreas Bergmann; Iain Squire; Dirk J van Veldhuisen; Kenneth Dickstein
C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
European heart journal 2009;30(10):1187-94.
2009: Kevin Damman; Vincent M van Deursen; gerjan navis; Adriaan A Voors; Dirk J van Veldhuisen; Hans L Hillege
Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.
Journal of the American College of Cardiology 2009;53(7):582-8.
2009: Kevin Damman; Dirk J van Veldhuisen; Hans L Hillege
Cardiac resynchronization therapy improves renal function: importance of forward and backward failure.
Journal of cardiac failure 2009;15(1):78-9; author reply 79-80.
2009: Ivonne Lesman-Leegte; Tiny Jaarsma; James C Coyne; Hans L Hillege; Dirk J van Veldhuisen; Robbert Sanderman
Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age- and gender-matched community controls.
Journal of cardiac failure 2009;15(1):17-23.
2009: René A Tio; Ali Dabeshlim; Hans-Marc J Siebelink; Johan de Sutter; Hans L Hillege; Clark J Zeebregts; Rudi A J O Dierckx; Dirk J van Veldhuisen; Felix Zijlstra; Riemer H J A Slart
Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(2):214-9.
2009: Tom D J Smilde; Kevin Damman; Pim van der Harst; gerjan navis; B Daan Westenbrink; Adriaan A Voors; Frans Boomsma; Dirk J van Veldhuisen; Hans L Hillege
Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2009;98(2):121-9.
2008: Auke H Brantsma; Stephan J L Bakker; Hans L Hillege; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(12):3851-8.
2008: Pieter J Vlaar; Tone Svilaas; Kevin Damman; Bart J G L de Smet; Jan G P Tijssen; Hans L Hillege; Felix Zijlstra
Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review.
Circulation 2008;118(18):1828-36.
2008: Sheba Ahmed; Michiel Rienstra; Harry J G M Crijns; Thera P Links; Ans C P Wiesfeld; Hans L Hillege; Hans A Bosker; Dirk J A Lok; Dirk J van Veldhuisen; Isabelle C Van Gelder
Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial.
JAMA : the journal of the American Medical Association 2008;300(15):1784-92.
2008: Kevin Damman; Dirk J van Veldhuisen; gerjan navis; Adriaan A Voors; Hans L Hillege
Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure.
European journal of heart failure 2008;10(10):997-1000.
2008: Hiddo J Lambers Heerspink; Daniela Dobre; Hans L Hillege; Diederick Grobbee; Dick De Zeeuw
Does the European clinical trials directive really improve clinical trial approval time?
British journal of clinical pharmacology 2008;66(4):546-50.
2008: Tiny Jaarsma; M H L van der Wal; Ivonne Lesman-Leegte; Marie Louise Luttik; Jochem Hogenhuis; N J Veeger; Robbert Sanderman; Arno Hoes; Wiek H van Gilst; D J A Lok; P H J M Dunselman; J G P Tijssen; Hans L Hillege; Dirk J van Veldhuisen
[Value of basic and intensive management of patients with heart failure; results of a randomised controlled clinical trial].
Nederlands tijdschrift voor geneeskunde 2008;152(37):2016-21.
2008: Hessel F Groenveld; James L Januzzi; Kevin Damman; Jan van Wijngaarden; Hans L Hillege; Dirk J van Veldhuisen; peter van der meer
Anemia and mortality in heart failure patients a systematic review and meta-analysis.
Journal of the American College of Cardiology 2008;52(10):818-27.
2008: Jan J J Aalberts; Tjalling W Waterbolk; J Peter van Tintelen; Hans L Hillege; Piet W Boonstra; Maarten P van den Berg
Prophylactic aortic root surgery in patients with Marfan syndrome: 10 years' experience with a protocol based on body surface area.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2008;34(3):589-94.
2008: Pim van der Harst; Folkert Asselbergs; Hans L Hillege; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Effect of fosinopril treatment on serum C-reactive protein levels in patients with microalbuminuria.
The American journal of cardiology 2008;102(2):223-5.
2008: Ivonne Lesman-Leegte; Tiny Jaarsma; Robbert Sanderman; Hans L Hillege; Dirk J van Veldhuisen
Determinants of depressive symptoms in hospitalised men and women with heart failure.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2008;7(2):121-6.
2008: Tiny Jaarsma; Martje H L van der Wal; Ivonne Lesman-Leegte; Marie Louise Luttik; Jochem Hogenhuis; Nic J G M Veeger; Robbert Sanderman; Arno Hoes; Wiek H van Gilst; Dirk J A Lok; Peter H J M Dunselman; Jan G P Tijssen; Hans L Hillege; Dirk J van Veldhuisen
Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
Archives of internal medicine 2008;168(3):316-24.
2008: Christiane A Geluk; Riksta Dikkers; Patrick J Perik; René A Tio; Marco J W Götte; Hans L Hillege; Rozemarijn Vliegenthart; Janneke B Houwers; Tineke P Willems; Matthijs Oudkerk; Felix Zijlstra
Measurement of coronary calcium scores by electron beam computed tomography or exercise testing as initial diagnostic tool in low-risk patients with suspected coronary artery disease.
European radiology 2008;18(2):244-52.
2008: Folkert Asselbergs; M P van den Berg; S J Bakker; J E Signorovitch; Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen
N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2008;16(3):73-8.
2008: R P F Dullaart; Susanna E Borggreve; Hans L Hillege; Geesje M Dallinga-Thie
The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.
Scandinavian journal of clinical and laboratory investigation 2008;68(2):99-105.
2008: Christiane A Geluk; Wendy J Post; Hans L Hillege; René A Tio; Jan G P Tijssen; RB van Dijk; W Arnold Dijk; Stephan J L Bakker; Paul E de Jong; Wiek H van Gilst; Felix Zijlstra
C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort.
Atherosclerosis 2008;196(1):372-82.
2008: Folkert Asselbergs; Pim van der Harst; Arie M Van Roon; Hans L Hillege; Paul E de Jong; Rijk O B Gans; Andries J Smit; Wiek H van Gilst
Long-term effects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects.
Atherosclerosis 2008;196(1):349-55.
2007: Pim van der Harst; Folkert Asselbergs; Hans L Hillege; Stephan J L Bakker; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Effect of withdrawal of pravastatin therapy on C-reactive protein and low-density lipoprotein cholesterol.
The American journal of cardiology 2007;100(10):1548-51.
2007: Folkert Asselbergs; scott williams; Patricia R Hebert; Christopher S Coffey; Hans L Hillege; Harold Snieder; gerjan navis; Douglas E Vaughan; Wiek H van Gilst; Jason Moore
The effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels are dependent on environmental context.
Human genetics 2007;122(3-4):275-81.
2007: Kevin Damman; gerjan navis; Adriaan A Voors; Folkert Asselbergs; Tom D J Smilde; John G F Cleland; Dirk J van Veldhuisen; Hans L Hillege
Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.
Journal of cardiac failure 2007;13(8):599-608.
2007: Tom D J Smilde; Mike W Zuurman; Hans L Hillege; Dirk J van Veldhuisen; Wiek H van Gilst; Gerrit van der Steege; Adriaan A Voors; Jan A Kors; Paul E de Jong; gerjan navis
Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.
American journal of hypertension 2007;20(10):1097-103.
2007: Rosa Laura E van Loon; Elke S Hoendermis; Marielle G J Duffels; Anton Vonk-Noordegraaf; Barbara J M Mulder; Hans L Hillege; Rolf M F Berger
Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?
American heart journal 2007;154(4):776-82.
2007: Kevin Damman; gerjan navis; Tom D J Smilde; Adriaan A Voors; Wim van der Bij; Dirk J van Veldhuisen; Hans L Hillege
Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.
European journal of heart failure 2007;9(9):872-8.
2007: Jochem Hogenhuis; Adriaan A Voors; Tiny Jaarsma; Arno Hoes; Hans L Hillege; Johannes A Kragten; Dirk J van Veldhuisen
Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure.
European journal of heart failure 2007;9(8):787-94.
2007: Wouter B A Eijkelkamp; Pieter A de Graeff; Dirk J van Veldhuisen; Richard P E van Dokkum; Ron T Gansevoort; Paul E de Jong; Dick De Zeeuw; Hans L Hillege
Effect of first myocardial ischemic event on renal function.
The American journal of cardiology 2007;100(1):7-12.
2007: Susanna E Borggreve; Hans L Hillege; Geesje M Dallinga-Thie; Paul E de Jong; Bruce Wolffenbuttel; Diederick Grobbee; Arie Van Tol; R P F Dullaart
High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides.
European heart journal 2007;28(8):1012-8.
2007: Folkert Asselbergs; scott williams; Patricia R Hebert; Christopher S Coffey; Hans L Hillege; gerjan navis; Douglas E Vaughan; Wiek H van Gilst; Jason Moore
Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.
Genomics 2007;89(3):362-9.
2007: Folkert Asselbergs; scott williams; Patricia R Hebert; Christopher S Coffey; Hans L Hillege; gerjan navis; Douglas E Vaughan; Wiek H van Gilst; Jason Moore
Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits.
Journal of thrombosis and haemostasis : JTH 2007;5(2):313-20.
2007: Christiane A Geluk; Riksta Dikkers; Jan A Kors; René A Tio; Riemer H J A Slart; Rozemarijn Vliegenthart; Hans L Hillege; Tineke P Willems; Paul E de Jong; Wiek H van Gilst; Matthijs Oudkerk; Felix Zijlstra
Measurement of coronary calcium scores or exercise testing as initial screening tool in asymptomatic subjects with ST-T changes on the resting ECG: an evaluation study.
BMC cardiovascular disorders 2007;7():19.
2007: Christiane A Geluk; René A Tio; Jan G P Tijssen; RB van Dijk; W A Dijk; Hans L Hillege; Paul E de Jong; Wiek H van Gilst; Felix Zijlstra
Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational study.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2007;15(4):133-41.
2007: B Daan Westenbrink; Folkert W Visser; Adriaan A Voors; Tom D J Smilde; Erik Lipsic; gerjan navis; Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen
Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well.
European heart journal 2007;28(2):166-71.
2006: Willemijn A K M Windt; Wouter B A Eijkelkamp; Robert H Henning; Alex C A Kluppel; Pieter A de Graeff; Hans L Hillege; Stefan Schäfer; Dick De Zeeuw; Richard P E van Dokkum
Renal damage after myocardial infarction is prevented by renin-angiotensin-aldosterone-system intervention.
Journal of the American Society of Nephrology : JASN 2006;17(11):3059-66.
2006: Tom D J Smilde; Dirk J van Veldhuisen; gerjan navis; Adriaan A Voors; Hans L Hillege
Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.
Circulation 2006;114(15):1572-80.
2006: Folkert Asselbergs; scott williams; Patricia R Hebert; Christopher S Coffey; Hans L Hillege; gerjan navis; Douglas E Vaughan; Wiek H van Gilst; Jason Moore
The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels.
Thrombosis and haemostasis 2006;96(4):471-7.
2006: Susanna E Borggreve; Hans L Hillege; Bruce Wolffenbuttel; Paul E de Jong; Mike W Zuurman; Gerrit van der Steege; Arie Van Tol; R P F Dullaart
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
The Journal of clinical endocrinology and metabolism 2006;91(9):3382-8.
2006: Nic J G M Veeger; Margriet Piersma-Wichers; Hans L Hillege; Harry J G M Crijns; Jan van der Meer
Early detection of patients with a poor response to vitamin K antagonists: the clinical impact of individual time within target range in patients with heart disease.
Journal of thrombosis and haemostasis : JTH 2006;4(7):1625-7.
2006: Jochem Hogenhuis; Adriaan A Voors; Tiny Jaarsma; Hans L Hillege; Arno Hoes; Dirk J van Veldhuisen
Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
American heart journal 2006;151(5):1012.e1-5.
2006: Michiel Rienstra; Isabelle C Van Gelder; Maarten P van den Berg; Frans Boomsma; Hans L Hillege; Dirk J van Veldhuisen
A comparison of low versus high heart rate in patients with atrial fibrillation and advanced chronic heart failure: effects on clinical profile, neurohormones and survival.
International journal of cardiology 2006;109(1):95-100.
2006: Jochem Hogenhuis; Tiny Jaarsma; Adriaan A Voors; Hans L Hillege; Ivonne Lesman; Dirk J van Veldhuisen
Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients.
International journal of cardiology 2006;108(1):63-7.
2006: Jarir Atthobari; Folkert Asselbergs; Cornelis Boersma; Robin de Vries; Hans L Hillege; Wiek H van Gilst; Ron T Gansevoort; Paul E de Jong; Lolkje T W de Jong van den Berg; Maarten J Postma
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
Clinical therapeutics 2006;28(3):432-44.
2006: Tom D J Smilde; Hans L Hillege; gerjan navis; Adriaan A Voors; Jan Brouwer; Dirk J van Veldhuisen
Difference in long-term prognostic value of renal function between ischemic and non-ischemic mild heart failure.
International journal of cardiology 2006;107(1):73-7.
2006: Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; john mcmurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick De Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
Circulation 2006;113(5):671-8.
2006: Hans L Hillege
Can an algorithm based on dipstick urine protein and urine specific gravity accurately predict proteinuria?
Nature clinical practice. Nephrology 2006;2(2):68-9.
2005: Tom D J Smilde; G C M Linssen; D Gallemann; T Kuhn; T Machnig; Peter G M Mol; Hans L Hillege; LM van Wijk; RB van Dijk; Dirk J van Veldhuisen
Influence of renal dysfunction on the pharmacokinetics of the selective Na+/H+ exchange inhibitor EMD 87 580 in patients with chronic heart failure.
International journal of clinical pharmacology and therapeutics 2005;43(11):507-16.
2005: Jacoline W Brinkman; Dick De Zeeuw; Jacko J Duker; Ron T Gansevoort; Ido P Kema; Hans L Hillege; Paul E de Jong; Stephan J L Bakker
Falsely low urinary albumin concentrations after prolonged frozen storage of urine samples.
Clinical chemistry 2005;51(11):2181-3.
2005: Auke H Brantsma; Stephan J L Bakker; Hans L Hillege; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.
Diabetes care 2005;28(10):2525-30.
2005: Dick De Zeeuw; Hans L Hillege; Paul E de Jong
The kidney, a cardiovascular risk marker, and a new target for therapy.
Kidney international. Supplement 2005;(98):S25-9.
2005: Adriaan A Voors; Colin J Petrie; Mark C Petrie; Andrew Charlesworth; Hans L Hillege; Felix Zijlstra; John J McMurray; Dirk J van Veldhuisen
Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure.
European heart journal 2005;26(17):1759-64.
2005: Susanna E Borggreve; Hans L Hillege; Bruce Wolffenbuttel; Paul E de Jong; Stephan J L Bakker; Gerrit van der Steege; Arie Van Tol; R P F Dullaart
The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
The Journal of clinical endocrinology and metabolism 2005;90(7):4198-204.
2005: Christiane A Geluk; Folkert Asselbergs; Hans L Hillege; Stephan J L Bakker; Paul E de Jong; Felix Zijlstra; Wiek H van Gilst
Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial.
European heart journal 2005;26(13):1314-20.
2005: Tom D J Smilde; Hans L Hillege; Dirk J van Veldhuisen; gerjan navis
Angiotensin-converting enzyme inhibitors and outcome among patients with heart failure and renal insufficiency: need for a prospective study.
Journal of the American College of Cardiology 2005;45(11):1905.
2005: Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
The association between atherosclerotic risk factors and renal function in the general population.
Kidney international 2005;67(5):1967-73.
2005: Ron T Gansevoort; Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong
The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population.
Kidney international. Supplement 2005;(94):S28-35.
2005: Tom D J Smilde; Folkert Asselbergs; Hans L Hillege; Adriaan A Voors; Jan A Kors; Ron T Gansevoort; Wiek H van Gilst; Paul E de Jong; Dirk J van Veldhuisen
Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.
American journal of hypertension 2005;18(3):342-7.
2005: Auke H Brantsma; Dick De Zeeuw; Hans L Hillege
Letter regarding article by Klausen et al, "very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes".
Circulation 2005;111(8):e110-1; author reply e110-1.
2005: Erik M Stuveling; Stephan J L Bakker; Hans L Hillege; Paul E de Jong; Rijk O B Gans; Dick De Zeeuw
Biochemical risk markers: a novel area for better prediction of renal risk?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(3):497-508.
2005: Folkert Asselbergs; Arie M Van Roon; Hans L Hillege; Paul E de Jong; Rijk O B Gans; Andries J Smit; Wiek H van Gilst
Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria.
Stroke; a journal of cerebral circulation 2005;36(3):649-53.
2005: Nic J G M Veeger; Margriet Piersma-Wichers; Jan G P Tijssen; Hans L Hillege; Jan van der Meer
Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism.
British journal of haematology 2005;128(4):513-9.
2005: Rudolf A de Boer; Hans L Hillege; Geert Tjeerdsma; Freek W A Verheugt; Dirk J van Veldhuisen
Both antiplatelet and anticoagulant therapy may favorably affect outcome in patients with advanced heart failure. A retrospective analysis of the PRIME-II trial.
Thrombosis research 2005;116(4):279-85.
2005: Jochem Hogenhuis; Adriaan A Voors; Tiny Jaarsma; Hans L Hillege; Frans Boomsma; Dirk J van Veldhuisen
Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP.
European journal of heart failure 2005;7(1):81-6.
2004: Folkert Asselbergs; Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Wilbert M T Janssen; Adriaan A Voors; Dick De Zeeuw; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Circulation 2004;110(18):2809-16.
2004: Jacoline W Brinkman; Stephan J L Bakker; Ron T Gansevoort; Hans L Hillege; Ido P Kema; Rijk O B Gans; Paul E de Jong; Dick De Zeeuw
Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC.
Kidney international. Supplement 2004;(92):S69-75.
2004: Jacobien C Verhave; Ron T Gansevoort; Hans L Hillege; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong
An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population.
Kidney international. Supplement 2004;(92):S18-21.
2004: Folkert Asselbergs; Hans L Hillege; Wiek H van Gilst
Framingham score and microalbuminuria: combined future targets for primary prevention?
Kidney international. Supplement 2004;(92):S111-4.
2004: Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; Wilbert M T Janssen; Ron T Gansevoort; gerjan navis; Dick De Zeeuw; Paul E de Jong
Sodium intake affects urinary albumin excretion especially in overweight subjects.
Journal of internal medicine 2004;256(4):324-30.
2004: Tom D J Smilde; Hans L Hillege; Adriaan A Voors; Peter H J M Dunselman; Dirk J van Veldhuisen
Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction.
The American journal of cardiology 2004;94(2):240-3.
2004: Tom D J Smilde; Hans L Hillege; gerjan navis; Frans Boomsma; Dick de Zeeuw; Dirk J van Veldhuisen
Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival.
American heart journal 2004;148(1):165-72.
2004: Jacobien C Verhave; Ron T Gansevoort; Hans L Hillege; Dick De Zeeuw; Gary C Curhan; Paul E de Jong
Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function.
Journal of the American Society of Nephrology : JASN 2004;15(5):1316-22.
2004: Eric L Knight; Jacobien C Verhave; Donna Spiegelman; Hans L Hillege; Dick De Zeeuw; Gary C Curhan; Paul E de Jong
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement.
Kidney international 2004;65(4):1416-21.
2004: Erik M Stuveling; Stephan J L Bakker; Hans L Hillege; Johannes G M Burgerhof; Paul E de Jong; Rijk O B Gans; Dick De Zeeuw
C-reactive protein modifies the relationship between blood pressure and microalbuminuria.
Hypertension 2004;43(4):791-6.
2004: Erik M Stuveling; Hans L Hillege; Stephan J L Bakker; Folkert Asselbergs; Paul E de Jong; Rijk O B Gans; Dick De Zeeuw
C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease.
Atherosclerosis 2004;172(1):107-14.
2003: Sara-Joan Pinto-Sietsma; Stefan-Martin Herrmann; Klaus Schmidt-Petersen; Tianhua Niu; Hans L Hillege; Wilbert M T Janssen; Dick De Zeeuw; Paul de Jong; Reinhold Kreutz
Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population.
Journal of the American Society of Nephrology : JASN 2003;14(10):2596-602.
2003: Folkert Asselbergs; Ad J van Boven; Erik M Stuveling; Gilles F H Diercks; Hans L Hillege; Jan A Kors; Paul E de Jong; Wiek H van Gilst
Relation of electrocardiographic abnormalities to levels of serum C-reactive protein.
The American journal of cardiology 2003;91(11):1358-60.
2003: Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; gerjan navis; Dick De Zeeuw; Paul E de Jong
Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women.
Journal of the American Society of Nephrology : JASN 2003;14(5):1330-5.
2003: Jacobien C Verhave; Corine P Baljé-Volkers; Hans L Hillege; Dick De Zeeuw; Paul E de Jong
The reliability of different formulae to predict creatinine clearance.
Journal of internal medicine 2003;253(5):563-73.
2003: Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen; gerjan navis; Diederick Grobbee; Pieter A de Graeff; Dick De Zeeuw
Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial.
European heart journal 2003;24(5):412-20.
2003: Erik M Stuveling; Hans L Hillege; Stephan J L Bakker; Rijk O B Gans; Paul E de Jong; Dick De Zeeuw
C-reactive protein is associated with renal function abnormalities in a non-diabetic population.
Kidney international 2003;63(2):654-61.
2003: Paul E de Jong; Hans L Hillege; Sara-Joan Pinto-Sietsma; Dick De Zeeuw
Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(1):10-3.
2002: Paul E de Jong; Jacobien C Verhave; Sara-Joan Pinto-Sietsma; Hans L Hillege
Obesity and target organ damage: the kidney.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26 Suppl 4():S21-4.
2002: Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Jan A Kors; Harry J G M Crijns; Diederick Grobbee; Paul E de Jong; Wiek H van Gilst
Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes.
Journal of the American College of Cardiology 2002;40(8):1401.
2002: Hans L Hillege; Vaclav Fidler; Gilles F H Diercks; Wiek H van Gilst; Dick De Zeeuw; Dirk J van Veldhuisen; Rijk O B Gans; Wilbert M T Janssen; Diederick Grobbee; Paul E de Jong
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.
Circulation 2002;106(14):1777-82.
2002: Jacobien C Verhave; Hans L Hillege; Dick De Zeeuw; Paul E de Jong
How to measure the prevalence of microalbuminuria in relation to age and gender?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(2):436-7; author reply 437.
2002: Gilles F H Diercks; Erik S G Stroes; Ad J van Boven; Arie M Van Roon; Hans L Hillege; Paul E de Jong; Andries J Smit; Rijk O B Gans; Harry J G M Crijns; ton rabelink; Wiek H van Gilst
Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects.
Atherosclerosis 2002;163(1):121-6.
2002: Gilles F H Diercks; Erik S G Stroes; Ad J van Boven; Arie M Van Roon; Hans L Hillege; Paul E de Jong; Andries J Smit; Rijk O B Gans; Harry J G M Crijns; ton rabelink; Wiek H van Gilst
Difference in the relation between urinary albumin excretion and carotid intima-media thickness in nondiabetic and type 2 diabetic subjects.
Diabetes care 2002;25(5):936-7.
2001: Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Jan A Kors; Wilbert M T Janssen; Diederick Grobbee; Harry J G M Crijns; Wiek H van Gilst
Relation between albumin in the urine and electrocardiographic markers of myocardial ischemia in patients without diabetes mellitus.
The American journal of cardiology 2001;88(7):771-4.
2001: Hans L Hillege; Wilbert M T Janssen; AA Bak; Gilles F H Diercks; Diederick Grobbee; Harry J G M Crijns; Wiek H van Gilst; Dick De Zeeuw; Paul E de Jong
Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity.
Journal of internal medicine 2001;249(6):519-26.
2000: Gilles F H Diercks; Ad J van Boven; Hans L Hillege; Wilbert M T Janssen; Jan A Kors; Paul E de Jong; Diederick Grobbee; Harry J G M Crijns; Wiek H van Gilst
Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study.
European heart journal 2000;21(23):1922-7.
2000: Wilbert M T Janssen; Hans L Hillege; Sara-Joan Pinto-Sietsma; AA Bak; Dick De Zeeuw; Paul E de Jong
Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2000;38(11):1107-10.
2000: Sara-Joan Pinto-Sietsma; J Mulder; Wilbert M T Janssen; Hans L Hillege; Dick De Zeeuw; Paul E de Jong
Smoking is related to albuminuria and abnormal renal function in nondiabetic persons.
Annals of internal medicine 2000;133(8):585-91.
2000: Sara-Joan Pinto-Sietsma; Wilbert M T Janssen; Hans L Hillege; gerjan navis; Dick De Zeeuw; Paul E de Jong
Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population.
Journal of the American Society of Nephrology : JASN 2000;11(10):1882-8.
2000: Hans L Hillege; A R Girbes; Pieter J de Kam; Frans Boomsma; Dick De Zeeuw; Andrew Charlesworth; John R Hampton; Dirk J van Veldhuisen
Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
Circulation 2000;102(2):203-10.
1997: S A van den Broek; Pieter A de Graeff; Dirk J van Veldhuisen; Wiek H van Gilst; Hans L Hillege; H Wesseling; K I Lie
Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failure.
Journal of cardiac failure 1997;3(3):165-71.